Dutch Health Minister Fleur Agema believes AI could halve healthcare's administrative burden by 2030. At kaiko.ai, we share her optimism—and see even greater potential. We're starting with the foundations. In collaboration with The Netherlands Cancer Institute and other partners, we’re using AI to streamline patient consultation preparation. Our platform extracts key information from medical records and referral letters, with the goals of saving doctors time and improving overall care quality. But that’s just the beginning. We’re pushing towards true multimodality in oncology. Imagine AI that can analyze not only text but also images and genetic data. We want to give cancer specialists the power to view, combine, and analyze all types of oncology data through AI. This isn’t just about efficiency; it’s about uncovering new insights. It’s about more accurate diagnoses and personalized treatments. It’s about empowering doctors to continuously learn and accelerate research. In short, it’s about better outcomes for cancer patients worldwide. What do you think? Can multimodal AI transform healthcare? We’d love to hear your thoughts. Het Financieele Dagblad #AIinHealthcare #HealthcareInnovation #HealthTech
kaiko.ai’s Post
More Relevant Posts
-
ARTICLE: AI in Healthcare: Empowering Humans, Not Replacing Them 💜 Read More: https://lnkd.in/gAv9HDWU At Azra AI, we understand the concerns surrounding AI in healthcare. Our mission is to support healthcare professionals—not replace them. Recently, nurses at HCA Healthcare voiced these concerns, emphasizing the importance of AI technologies that empower, not diminish, their critical role in patient care. Our proven AI platform enhances the work of oncology navigators, and oncology data specialists by automating routine tasks, streamlining workflows, and allowing more time to be dedicated to patient care. With real-time, actionable insights and seamless integration, Azra AI serves as a valuable ally in the fight against cancer and other complex conditions. Read the full article on our website to discover how Azra AI is building a future where AI and healthcare professionals work hand in hand for better patient outcomes by clicking the link above! #AIinHealthcare #EmpoweringClinicians #AzraAI #WinningTogether #OncologyServiceLines
AI in Healthcare: Empowering Humans, not replacing them.
To view or add a comment, sign in
-
From #ALLIN2023: AI for healthcare 🩺 Last September, executives from Dialogue, AlayaCare, Roche, Signal 1 , CHUM - Centre hospitalier de l'Université de Montréal, Medeloop.ai, Gray Oncology Solutions and integrate.ai took part in a discussion moderated by Digital supercluster's Sue Paish on the potential of AI technologies to revolutionize patient care, illness management and drug discovery. Find out more in this exclusive article on the brand-new #ALLIN blog - a presentation by SCALE AI | Grappe d’innovation mondiale du Canada en IA 👉 https://lnkd.in/eS3k--Fs
From ALL IN 2023 | How AI is Transforming Healthcare
allinevent.ai
To view or add a comment, sign in
-
The UK government's decision to cut the NHS AI Lab's budget from £250m to £139m sends a concerning signal about the future of AI in healthcare. This reduction could have profound implications for innovation and patient care. Launched in 2019, the NHS AI Lab aimed to tackle significant health challenges, from early cancer detection to personalised care. With the budget now slashed, the momentum in these critical areas could be severely hindered. Despite the cut, £113m has been invested in 83 AI projects, supporting health start-ups and research teams. However, the broader potential of AI in the NHS remains largely untapped and is at risk of stalling. The King’s Fund highlights a core issue: short-term funding undermines the long-term integration of AI in the NHS. Sustained investment is crucial for building the necessary expertise and capabilities. The NHS AI Lab’s initiatives, including the AI Ethics Initiative and the AI Regulation programme, are essential for safe and effective AI deployment. These programmes ensure that AI technologies are developed and used responsibly. The reduced funding may slow the progress of AI-driven advancements in healthcare, such as earlier stroke treatment and personalised heart attack risk assessments, which are already benefiting NHS patients. An independent evaluation of the AI investments is set to begin, aiming to assess the impact and effectiveness of the funded projects. This evaluation is vital for understanding what works and where improvements are needed. Collaboration with the Cabinet Office’s Incubator for Artificial Intelligence will focus on non-clinical AI solutions, ensuring data privacy and security. However, the absence of new medical AI developments could limit clinical advancements. The NHS must navigate these funding challenges while maintaining its commitment to leveraging AI for better patient outcomes. Strategic investment and support are crucial for realising AI's full potential in healthcare. The future of AI in the NHS hangs in the balance. Will the UK government step up to provide the necessary long-term funding, or will short-term cuts continue to impede progress? The answer will shape the future of healthcare innovation. What would you add? Found this useful? Repost ♻️ to help your network. Join a community of 85,712+ HealthTech leaders finding the ideas, people, innovations and technologies that are shaping the future of healthcare. 👉 http://lnkd.in/eExMcaG6
To view or add a comment, sign in
-
NHS England slashes investment in NHS AI Lab by £111m - Digital Health #NHS #AI Lab Funding Cut by £111m NHS England has reduced its funding for the NHS AI Lab by £111 million. This decision has raised concerns about the future of AI projects in healthcare. #Impact on AI Research and Development The funding cut will have a significant impact on AI research and development within the NHS. Projects that were in progress may be delayed or canceled due to lack of funding. #Potential Consequences for Patient Care The reduction in funding for the NHS AI Lab could have potential consequences for patient care. AI technologies have the potential to improve efficiency and outcomes in healthcare, but without adequate funding, these benefits may not be realized. #Need for Continued Investment in AI Healthcare IT professionals stress the importance ai.mediformatica.com #health #nhsailab #digital #programme #budget #digitalhealth #investment #news #nhsailabprogramme #nhsengland #cabinetoffice #cancer #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3KyFfYN)
DHSC slashes investment in NHS AI Lab by £111m
https://www.digitalhealth.net
To view or add a comment, sign in
-
🚀 You can't improve what you don't measure! 🚀 We're thrilled to announce the release of our latest blog post, "Revolutionising Cancer Referrals with Graph-Powered AI Agents," written by our founders. In this post, William Maw and Robert Smith dive deep into how our semi-autonomous AI Agent, LEO, leverages cutting-edge AI and automation engineering techniques to tackle the challenges of the NHS 28-day Faster Diagnosis Standard referral process. Discover how we're using LangChain, Named Entity Extraction, Reasoning, Summarisation, and Neo4j graph-based memory to revolutionise cancer referrals and improve patient outcomes. 🌟 Key Highlights: - Addressing the inefficiencies in cancer referrals - Ensuring completeness and appropriateness of referral information - Reducing decision-making time for clinicians by more than 66% - Enhancing validation and verification through graph-based memory Read the full post to learn how LEO is setting new standards in healthcare AI and paving the way for more streamlined, patient-centric care processes. 🔗 Read the Blog Post: Join us in our mission to transform healthcare delivery through innovative AI solutions! #HealthcareInnovation #AIinHealthcare #CancerReferrals #FasterDiagnosis #HealthcareCoPilot #LEO #AI #TechForGood #Langchain #Neo4j Philip Rathle Ian Smith Steve Boam
Revolutionising Cancer Referrals with Graph-Powered AI Agents
healthcarecopilot.ai
To view or add a comment, sign in
-
Healthcare innovation in AI and brain scans from Belgium: icometrix has already analysed 200,000 brains with its AI model, and is an important piece of the puzzle in understanding, monitoring and treating neurological disorders. Rad more on the in the report on "De Tijd" (sorry, it's in Dutch only) #healthcare #ai #healthcareinnovation #innovation
Leuvense AI-specialist die al 200.000 hersenen analyseerde, staat voor grote doorbraak in VS
tijd.be
To view or add a comment, sign in
-
I deeply value the role of carers and medical professionals in looking after patients. I've seen this with people close to me. This is why I find AI innovations for healthcare professionals and their patients particularly inspiring. Here are a few that caught my eye this year: Ottobock is a German company reputed for prosthetics and orthotics. It has started to use Microsoft AI tools to create and analyze super-detailed body part images and to design prosthetics that fit perfectly and are more comfortable for patients. In a profession that suffers from skills shortages, using AI also means that less experienced technicians can deliver high-quality results. At @stjamesshospitaldublin, EY has worked on a project using Microsoft technology to shorten lab analysis times. For example, lab analysis for MRSA – a.k.a. the hospital superbug - has been cut from nine hours to just two, a crucial saving when containing MRSA outbreaks. A digital health hub collaboration between Finnish university hospitals, Terveyskylä - Hälsobynä, gives patients a huge wealth of information and guidance for managing a whole range of conditions. Diabetics, for example, can have guidance on monitoring blood sugar, insulin therapy and more. It's a perfect example of reducing strain on the healthcare system while empowering the patient. So far, so good - but we must continue to build trust in AI for healthcare. This year, we announced the expansion to Europe of TRAIN, the Trustworthy and Responsible AI Network. TRAIN brings together hospitals, researchers, and technologists from across Europe to rigorously test AI systems and to share best practices. Research from Microsoft Health Futures show the promise of what’s yet to come. Project InnerEye uses AI to help doctors plan radiotherapy treatments much faster Project InnerEye toolkits are now open-source, so that others can develop their own solutions. Another example is the Early Detection of Esophageal Cancer project which aims to identify the disease earlier and improve survival rates. Esophageal cancer is the sixth leading cause of cancer deaths globally, largely because it’s often caught too late. Our health is our wealth, and the progress we’re seeing with AI in healthcare - together with the innovations on the horizon - gives us every reason to feel optimistic for 2025 and beyond. Tjade Stroband, Thomas Spörri, Gabriel Lopez Serrano, Elena Bonfiglioli, Kevin O'Leary, Ruthy Kaidar #AI #Healthcare
To view or add a comment, sign in
-
This is a great post by Thomas Hagemeijer. The commenters provide thoughtful insights and clarifications-a reminder to dig deeper in order to better understand the numbers as they are presented. #AI #FDAapprovals #AIapprovals #machinelearning #medicaldevices #biotech
The FDA has recently released a new batch of approvals for AI algorithms in healthcare, and the exponential growth continues! We wrote down a few thoughts. 1️⃣ (𝐑𝐞-)-𝐂𝐞𝐫𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐢𝐬 𝐨𝐧𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐭𝐨 𝐨𝐯𝐞𝐫𝐜𝐨𝐦𝐞 When an AI algorithm in #healthcare undergoes an update or small change, it must be re-certified. This is a major challenge in the sector. Fortunately, some companies like Scarlet are currently addressing this issue. 2️⃣ 𝐁𝐢𝐠 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 𝐚𝐫𝐞 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐛𝐮𝐭 𝐢𝐭 𝐢𝐬 𝐬𝐭𝐢𝐥𝐥 𝐚 𝐟𝐫𝐚𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 Siemens Healthineers, Canon, and GE Healthcare have the highest number of AI algorithms approved (between 25 and 75 approvals each). However, scale-ups like AIDOC (23 algorithms approved) and Viz.ai (10 algorithms approved) are also strong contenders. The top 10 companies account for 20% of total FDA approvals, with newcomers entering the market, indicating that it is still nascent and fragmented. 3️⃣ 𝐌&𝐀 𝐢𝐬 𝐚𝐥𝐫𝐞𝐚𝐝𝐲 𝐡𝐚𝐩𝐩𝐞𝐧𝐢𝐧𝐠 𝐟𝐨𝐫 𝐭𝐡𝐨𝐬𝐞 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐥𝐚𝐠𝐠𝐢𝐧𝐠 𝐛𝐞𝐡𝐢𝐧𝐝 For example, Philips, which has been much less active than its peers, has caught up by acquiring Dia Imaging Analysis from Israel (3 algorithms). 4️⃣ 𝐓𝐡𝐞 𝐟𝐮𝐥𝐥 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟 𝐀𝐈 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰 𝐡𝐚𝐬 𝐲𝐞𝐭 𝐭𝐨 𝐛𝐞 𝐩𝐫𝐨𝐯𝐞𝐧 The first large-scale scientific study demonstrating the value of AI in mammography (a subcategory of radiology) was published in August 2023, sponsored by the Swedish Cancer Society. The results showed that AI in mammography enables a 50% efficiency gain. However, the value of AI has just been demonstrated for this one subcategory of radiology, the most established AI category so far. There is still a long way to go. 5️⃣ "𝐅𝐃𝐀 𝐚𝐩𝐩𝐫𝐨𝐯𝐞𝐝" 𝐝𝐨𝐞𝐬 𝐧𝐨𝐭 𝐦𝐞𝐚𝐧 "𝐇𝐂𝐏 𝐚𝐩𝐩𝐫𝐨𝐯𝐞𝐝" "We started using an FDA-approved algorithm, but then we saw it wasn't working well enough because of too many false alarms and problems fitting into our workflow." This is what the head of digital of a leading hospital chain told me. Getting FDA approval is just the beginning of a longer journey. --------- HLTH Europe starts on Monday! I cannot wait to discuss about Ai in health with leading innovators. I hope to see you all there! #healthtech #ai #fda
To view or add a comment, sign in
-
The speed towards #AI regulation in 2023-24 shows the pace of anticipated acceleration of industry growth. The expediency of these regulations are very interesting to see. #aiinhealthcare #healthcare #ethics #ai #ml #givemhealth #population #health #regulation
The FDA has recently released a new batch of approvals for AI algorithms in healthcare, and the exponential growth continues! We wrote down a few thoughts. 1️⃣ (𝐑𝐞-)-𝐂𝐞𝐫𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐢𝐬 𝐨𝐧𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐭𝐨 𝐨𝐯𝐞𝐫𝐜𝐨𝐦𝐞 When an AI algorithm in #healthcare undergoes an update or small change, it must be re-certified. This is a major challenge in the sector. Fortunately, some companies like Scarlet are currently addressing this issue. 2️⃣ 𝐁𝐢𝐠 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 𝐚𝐫𝐞 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐛𝐮𝐭 𝐢𝐭 𝐢𝐬 𝐬𝐭𝐢𝐥𝐥 𝐚 𝐟𝐫𝐚𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 Siemens Healthineers, Canon, and GE Healthcare have the highest number of AI algorithms approved (between 25 and 75 approvals each). However, scale-ups like AIDOC (23 algorithms approved) and Viz.ai (10 algorithms approved) are also strong contenders. The top 10 companies account for 20% of total FDA approvals, with newcomers entering the market, indicating that it is still nascent and fragmented. 3️⃣ 𝐌&𝐀 𝐢𝐬 𝐚𝐥𝐫𝐞𝐚𝐝𝐲 𝐡𝐚𝐩𝐩𝐞𝐧𝐢𝐧𝐠 𝐟𝐨𝐫 𝐭𝐡𝐨𝐬𝐞 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐥𝐚𝐠𝐠𝐢𝐧𝐠 𝐛𝐞𝐡𝐢𝐧𝐝 For example, Philips, which has been much less active than its peers, has caught up by acquiring Dia Imaging Analysis from Israel (3 algorithms). 4️⃣ 𝐓𝐡𝐞 𝐟𝐮𝐥𝐥 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟 𝐀𝐈 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰 𝐡𝐚𝐬 𝐲𝐞𝐭 𝐭𝐨 𝐛𝐞 𝐩𝐫𝐨𝐯𝐞𝐧 The first large-scale scientific study demonstrating the value of AI in mammography (a subcategory of radiology) was published in August 2023, sponsored by the Swedish Cancer Society. The results showed that AI in mammography enables a 50% efficiency gain. However, the value of AI has just been demonstrated for this one subcategory of radiology, the most established AI category so far. There is still a long way to go. 5️⃣ "𝐅𝐃𝐀 𝐚𝐩𝐩𝐫𝐨𝐯𝐞𝐝" 𝐝𝐨𝐞𝐬 𝐧𝐨𝐭 𝐦𝐞𝐚𝐧 "𝐇𝐂𝐏 𝐚𝐩𝐩𝐫𝐨𝐯𝐞𝐝" "We started using an FDA-approved algorithm, but then we saw it wasn't working well enough because of too many false alarms and problems fitting into our workflow." This is what the head of digital of a leading hospital chain told me. Getting FDA approval is just the beginning of a longer journey. --------- HLTH Europe starts on Monday! I cannot wait to discuss about Ai in health with leading innovators. I hope to see you all there! #healthtech #ai #fda
To view or add a comment, sign in
1,974 followers